A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
K36 Therapeutics, Inc.
Varian, a Siemens Healthineers Company
Blue Earth Therapeutics Ltd
DL Analytics
NanOlogy, LLC
AgonOx, Inc.
Eli Lilly and Company